Jonathan D. Root - 22 Jun 2020 Form 4 Insider Report for Inari Medical, Inc.

Role
Director
Signature
/s/ Angela Ahmad, attorney-in-fact for Jonathan D. Root
Issuer symbol
N/A
Transactions as of
22 Jun 2020
Net transactions value
+$28,484
Form type
4
Filing time
18 Mar 2022, 17:10:21 UTC
Next filing
18 Mar 2022

Key filing fact

Jonathan D. Root filed Form 4 for Inari Medical, Inc. on 18 Mar 2022.

Key facts

  • This page summarizes Jonathan D. Root's Form 4 filing for Inari Medical, Inc..
  • 2 reported transactions and 0 derivative rows are listed below.
  • Filing timestamp: 18 Mar 2022, 17:10.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: +$28,484.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Transactions Table

NARI transaction

Common Stock

Purchase

Transaction value
$1,492
Shares
+32
Change %
Price
$46.61
Shares after
32
Date
22 Jun 2020
Ownership
Directly Owned by Spouse
Footnotes
F1
NARI transaction

Common Stock

Purchase

Transaction value
$26,992
Shares
+303
Change %
+947%
Price
$89.08
Shares after
335
Date
15 Nov 2021
Ownership
Directly Owned by Spouse
Footnotes
F1
NARI holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
526,226
Date
22 Jun 2020
Ownership
Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares are being reported following the discovery that shares of the issuer were purchased in discretionary IRA accounts held by the spouse of the reporting person. The reporting person is not an owner of such IRA accounts. The total in Column 5 reflects amounts held as of the date of this filing.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .